Видео ютуба по тегу Speaker: Lars Bullinger

HARMONY Alliance expert interview: Lars Bullinger, Charite
HARMONY Alliance expert interview: Lars Bullinger, Charite
ALAN Webinar : How is the risk classification in AML driving treatment intensity ?
ALAN Webinar : How is the risk classification in AML driving treatment intensity ?
HARMONY: Enabling better and faster treatment for patients with haematological malignancies
HARMONY: Enabling better and faster treatment for patients with haematological malignancies
Translational research in Berlin to improve AML treatment outcomes
Translational research in Berlin to improve AML treatment outcomes
Reassuring patients with AML
Reassuring patients with AML
Bringing precision medicine and MRD into clinical strategies
Bringing precision medicine and MRD into clinical strategies
HARMONY: a collaboration between 51 partners
HARMONY: a collaboration between 51 partners
Next-generation sequencing: a breakthrough in sequencing technology
Next-generation sequencing: a breakthrough in sequencing technology
Adapting AML treatment for elderly patients
Adapting AML treatment for elderly patients
The Power of Integrating Harmonized AML Patient Data in Hematology Research
The Power of Integrating Harmonized AML Patient Data in Hematology Research
Next-generation sequencing: revolutionising molecular diagnostics
Next-generation sequencing: revolutionising molecular diagnostics
The challenges facing elderly AML treatment
The challenges facing elderly AML treatment
Novel insights into genomic classification and prognosis in AML
Novel insights into genomic classification and prognosis in AML
Targeted therapy for AML: current outlook and future potential
Targeted therapy for AML: current outlook and future potential
The “controversial situations” seen in FLT3-mutated AML patients
The “controversial situations” seen in FLT3-mutated AML patients
getITD for FLT3-ITD-based MRD monitoring in AML
getITD for FLT3-ITD-based MRD monitoring in AML
Minimal gene panel in AML
Minimal gene panel in AML
So About Speakers, These are the Ones
So About Speakers, These are the Ones
EHA: AML immuno-oncology updates
EHA: AML immuno-oncology updates
Innovations in MDS and AML treatment
Innovations in MDS and AML treatment